Report Detail
Global Thyroid Gland Disorders Treatment Market Insights, Forecast to 2025
- RnM2398840 |
- 25 April, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
The global Thyroid Gland Disorders Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Thyroid Gland Disorders Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Thyroid Gland Disorders Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Thyroid Gland Disorders Treatment in these regions.
This research report categorizes the global Thyroid Gland Disorders Treatment market by top players/brands, region, type and end user. This report also studies the global Thyroid Gland Disorders Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Pfizer, Inc
Novartis International AG
Abbott Laboratories
AbbVie, Inc
Sanofi
Takeda Pharmaceutical
Allergan Plc
Merck KGaA
Lannett Company, Inc
Mylan N.V
Market size by Product
Hypothyroidism
Hyperthyroidism
Market size by End User
Hospitals
Clinics
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Thyroid Gland Disorders Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Thyroid Gland Disorders Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Thyroid Gland Disorders Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Thyroid Gland Disorders Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Thyroid Gland Disorders Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Thyroid Gland Disorders Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Thyroid Gland Disorders Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Thyroid Gland Disorders Treatment Market Size Growth Rate by Product
- 1.4.2 Hypothyroidism
- 1.4.3 Hyperthyroidism
- 1.5 Market by End User
- 1.5.1 Global Thyroid Gland Disorders Treatment Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Thyroid Gland Disorders Treatment Market Size
- 2.1.1 Global Thyroid Gland Disorders Treatment Revenue 2014-2025
- 2.1.2 Global Thyroid Gland Disorders Treatment Sales 2014-2025
- 2.2 Thyroid Gland Disorders Treatment Growth Rate by Regions
- 2.2.1 Global Thyroid Gland Disorders Treatment Sales by Regions
- 2.2.2 Global Thyroid Gland Disorders Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Thyroid Gland Disorders Treatment Sales by Manufacturers
- 3.1.1 Thyroid Gland Disorders Treatment Sales by Manufacturers
- 3.1.2 Thyroid Gland Disorders Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Thyroid Gland Disorders Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Thyroid Gland Disorders Treatment Revenue by Manufacturers
- 3.2.1 Thyroid Gland Disorders Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Thyroid Gland Disorders Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Thyroid Gland Disorders Treatment Price by Manufacturers
- 3.4 Thyroid Gland Disorders Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Thyroid Gland Disorders Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Thyroid Gland Disorders Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Thyroid Gland Disorders Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Thyroid Gland Disorders Treatment Sales by Product
- 4.2 Global Thyroid Gland Disorders Treatment Revenue by Product
- 4.3 Thyroid Gland Disorders Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Thyroid Gland Disorders Treatment Breakdown Data by End User
6 North America
- 6.1 North America Thyroid Gland Disorders Treatment by Countries
- 6.1.1 North America Thyroid Gland Disorders Treatment Sales by Countries
- 6.1.2 North America Thyroid Gland Disorders Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Thyroid Gland Disorders Treatment by Product
- 6.3 North America Thyroid Gland Disorders Treatment by End User
7 Europe
- 7.1 Europe Thyroid Gland Disorders Treatment by Countries
- 7.1.1 Europe Thyroid Gland Disorders Treatment Sales by Countries
- 7.1.2 Europe Thyroid Gland Disorders Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Thyroid Gland Disorders Treatment by Product
- 7.3 Europe Thyroid Gland Disorders Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Thyroid Gland Disorders Treatment by Countries
- 8.1.1 Asia Pacific Thyroid Gland Disorders Treatment Sales by Countries
- 8.1.2 Asia Pacific Thyroid Gland Disorders Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Thyroid Gland Disorders Treatment by Product
- 8.3 Asia Pacific Thyroid Gland Disorders Treatment by End User
9 Central & South America
- 9.1 Central & South America Thyroid Gland Disorders Treatment by Countries
- 9.1.1 Central & South America Thyroid Gland Disorders Treatment Sales by Countries
- 9.1.2 Central & South America Thyroid Gland Disorders Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Thyroid Gland Disorders Treatment by Product
- 9.3 Central & South America Thyroid Gland Disorders Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Thyroid Gland Disorders Treatment by Countries
- 10.1.1 Middle East and Africa Thyroid Gland Disorders Treatment Sales by Countries
- 10.1.2 Middle East and Africa Thyroid Gland Disorders Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Thyroid Gland Disorders Treatment by Product
- 10.3 Middle East and Africa Thyroid Gland Disorders Treatment by End User
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Thyroid Gland Disorders Treatment Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Pfizer, Inc
- 11.2.1 Pfizer, Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer, Inc Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer, Inc Thyroid Gland Disorders Treatment Products Offered
- 11.2.5 Pfizer, Inc Recent Development
- 11.3 Novartis International AG
- 11.3.1 Novartis International AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis International AG Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis International AG Thyroid Gland Disorders Treatment Products Offered
- 11.3.5 Novartis International AG Recent Development
- 11.4 Abbott Laboratories
- 11.4.1 Abbott Laboratories Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Abbott Laboratories Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Abbott Laboratories Thyroid Gland Disorders Treatment Products Offered
- 11.4.5 Abbott Laboratories Recent Development
- 11.5 AbbVie, Inc
- 11.5.1 AbbVie, Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 AbbVie, Inc Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 AbbVie, Inc Thyroid Gland Disorders Treatment Products Offered
- 11.5.5 AbbVie, Inc Recent Development
- 11.6 Sanofi
- 11.6.1 Sanofi Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sanofi Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sanofi Thyroid Gland Disorders Treatment Products Offered
- 11.6.5 Sanofi Recent Development
- 11.7 Takeda Pharmaceutical
- 11.7.1 Takeda Pharmaceutical Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Takeda Pharmaceutical Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Takeda Pharmaceutical Thyroid Gland Disorders Treatment Products Offered
- 11.7.5 Takeda Pharmaceutical Recent Development
- 11.8 Allergan Plc
- 11.8.1 Allergan Plc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Allergan Plc Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Allergan Plc Thyroid Gland Disorders Treatment Products Offered
- 11.8.5 Allergan Plc Recent Development
- 11.9 Merck KGaA
- 11.9.1 Merck KGaA Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Merck KGaA Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Merck KGaA Thyroid Gland Disorders Treatment Products Offered
- 11.9.5 Merck KGaA Recent Development
- 11.10 Lannett Company, Inc
- 11.10.1 Lannett Company, Inc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Lannett Company, Inc Thyroid Gland Disorders Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Lannett Company, Inc Thyroid Gland Disorders Treatment Products Offered
- 11.10.5 Lannett Company, Inc Recent Development
- 11.11 Mylan N.V
12 Future Forecast
- 12.1 Thyroid Gland Disorders Treatment Market Forecast by Regions
- 12.1.1 Global Thyroid Gland Disorders Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Thyroid Gland Disorders Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Thyroid Gland Disorders Treatment Market Forecast by Product
- 12.2.1 Global Thyroid Gland Disorders Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Thyroid Gland Disorders Treatment Revenue Forecast by Product 2019-2025
- 12.3 Thyroid Gland Disorders Treatment Market Forecast by End User
- 12.4 North America Thyroid Gland Disorders Treatment Forecast
- 12.5 Europe Thyroid Gland Disorders Treatment Forecast
- 12.6 Asia Pacific Thyroid Gland Disorders Treatment Forecast
- 12.7 Central & South America Thyroid Gland Disorders Treatment Forecast
- 12.8 Middle East and Africa Thyroid Gland Disorders Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Thyroid Gland Disorders Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Thyroid Gland Disorders Treatment . Industry analysis & Market Report on Thyroid Gland Disorders Treatment is a syndicated market report, published as Global Thyroid Gland Disorders Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Thyroid Gland Disorders Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
